SCHEMBL2401083

SCHEMBL2401083

COc1ccc(Br)cc1-c1nc2c(F)cccc2o1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.54
HTT P42858 1/20 0.54
TSHR P16473 1/20 0.46
RAB9A P51151 1/20 0.46
AMY1A P0DUB6 1/20 0.41
POLB P06746 1/20 0.40
DRD2 P14416 2/20 0.40
DRD4 P21917 2/20 0.40
DRD3 P35462 2/20 0.40
CSNK2A2 P19784 1/20 0.38
CSNK2B P67870 1/20 0.38
ALDH1A1 P00352 2/20 0.38
MAPT P10636 2/20 0.38
PTGS2 P35354 1/20 0.38
KDM4E B2RXH2 1/20 0.38
MGAM O43451 1/20 0.38
GAA P10253 1/20 0.38
SI P14410 1/20 0.38
MGAM2 Q2M2H8 1/20 0.38
MC4R P32245 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2402349 0.82 NPC1 (0.44) NPC1HTTTSHRRAB9APOLB
SCHEMBL14764726 0.81 NPC1 (0.37) NPC1HTTRAB9AALDH1A1MAPT
SCHEMBL2424469 0.78 CSF1R (0.38) NPC1HTTALDH1A1MAPTPTGS2
SCHEMBL2386983 0.73 MET (0.41) NPC1HTTRAB9APOLBMAPT
SCHEMBL5340563 0.72 KDM4E (0.48) NPC1HTTTSHRRAB9AALDH1A1
SCHEMBL15886933 0.72 AGPAT2 (0.36) NPC1RAB9AALDH1A1MAPTKDM4E
SCHEMBL30842547 0.71 NPC1 (0.47) NPC1HTTTSHRRAB9APOLB
SCHEMBL5340379 0.71 KDM4E (0.44) NPC1HTTTSHRRAB9AALDH1A1
SCHEMBL2386233 0.71 F2RL3 (0.41) NPC1RAB9APOLBALDH1A1MAPT
SCHEMBL14771374 0.69 TOP2A (0.35) ALDH1A1MAPTKDM4EPSEN1PSEN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2542545-A1 INHIBITORS OF HEPATITIS C VIRUS NS5B POLYMERASE Merck Sharp & Dohme Corp. (US) 2013-01-09 EP disclosed
US-20120328569-A1 INHIBITORS OF HEPATITIS C VIRUS NS5B POLYMERASE MERCK SHARP & DOHME CORP. 2012-12-27 US disclosed
WO-2011106992-A1 INHIBITORS OF HEPATITIS C VIRUS NS5B POLYMERASE MERCK SHARP & DOHME CORP. (US) 2011-09-09 WO disclosed
WO-2011106992-A1 INHIBITORS OF HEPATITIS C VIRUS NS5B POLYMERASE MERCK SHARP & DOHME CORP. (US) 2011-09-09 WO disclosed
WO-2011106986-A1 INHIBITORS OF HEPATITIS C VIRUS NS5B POLYMERASE MERCK SHARP & DOHME CORP. (US) 2011-09-09 WO disclosed
WO-2011106986-A1 INHIBITORS OF HEPATITIS C VIRUS NS5B POLYMERASE MERCK SHARP & DOHME CORP. (US) 2011-09-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120328569-A1 INHIBITORS OF HEPATITIS C VIRUS NS5B POLYMERASE HCCS, EIF2AK2, RNGTT NPC1 296/4885HTT 4338/4885TSHR 4699/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.